Cabrini Hospital

Clayton, Victoria 3168

1 studies enrolling now · 1 studies all time

What they study most

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Studies at this site

• Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer — Recruiting now